Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Boston Scientific Shareholders Between July 23, 2025 and February 3, 2026 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
-
The case alleges Boston Scientific misled investors about its US EP segment's growth and competitive risks.
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Boston Scientific To Contact Him Directly To Discuss Their Options If you...
-
Boston Scientific Shareholders Between July 23, 2025 and February 3, 2026 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
-
The case alleges Boston Scientific misled investors about its US EP segment's growth and competitive risks.
-
Boston Scientific Shareholders Between July 23, 2025 and February 3, 2026 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
-
Notice Shareholders of Boston Scientific (NYSE: BSX): Corcept Therapeutics (NASDAQ: CORT); Nektar Therapeutics (NASDAQ: NKTR); and Unicycive (NASDAQ: UNCY)
-
LOS ANGELES, March 10, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Boston Scientific Corporation, (“Boston Scientific” or the "Company") (NYSE: BSX) investors off a class action on behalf...
-
Boston Scientific Shareholders Between July 23, 2025 and February 3, 2026 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
-
Boston Scientific Shareholders Between July 23, 2025 and February 3, 2026 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit